tradingkey.logo

BRIEF-Eli Lilly Reports Q4 Worldwide Mounjaro Revenue Increased 60% To $3.53 Billion

ReutersFeb 6, 2025 12:15 PM

- Eli Lilly and Co LLY.N:

  • ELI LILLY: FOR Q4, WORLDWIDE MOUNJARO REVENUE INCREASED 60% TO $3.53 BILLION

  • ELI LILLY: FOR Q4, U.S. ZEPBOUND REVENUE WAS $1.91 BILLION

Source text: ID:nPnbC9Q5fa

Further company coverage: LLY.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI